Medications for Bardet-Biedl Syndrome
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Bardet-Biedl Syndrome.
Found 1 Approved Drug for Bardet-Biedl Syndrome
Imcivree
Generic Name
Setmelanotide
Imcivree
Generic Name
Setmelanotide
Form: Solution
Method of administration: Subcutaneous
FDA approval date: December 14, 2020
Classification: Melanocortin 4 Receptor Agonist
IMCIVREE is indicated to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 2 years and older with syndromic or monogenic obesity due to: Bardet-Biedl syndrome (BBS) [see Dosage and Administration.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances